The commercialisation of software and artificial intelligence as medical devices (SaMD and AIaMD) has long encountered an operational bottleneck generated by the structural mismatch between rapid algorithmic development cycles and legacy medical device conformity assessment protocols. Traditional certification bodies, established primarily around electromechanical and physical biomedical hardware engineering paradigms, enforce linear, document-heavy audits that frequently imp